Interestingly, RA increased the expression levels of gut-homing molecules CCR9 and α4β7 in Th17 cells, and populations of CCR9 and α4β7 double-positive Th17 cells increased markedly in the RA treatment groups (Figure 4C). Here, CCR9 is linked to rheumatoid arthritis.